Jean-Francois H. Geschwind, MD is the new Chairman of Radiology and Biomedical Imaging at Yale School of Medicine, Radiologist in Chief at Yale-New Haven Hospital and also a Professor of Radiology and Oncology at Yale University School of Medicine. Originally from Paris, France, Dr. Geschwind received his medical degree in 1991 from Boston University School of Medicine. He completed his residency training in Diagnostic Radiology at the University of California San Francisco and Fellowship in Vascular and Interventional Radiology in 1998 at Johns Hopkins University School of Medicine where he remained on faculty and as the Chief of Vascular and Interventional Radiology since 2002.
Dr. Geschwind is recognized as a key expert in the field of liver cancer and he has focused his research on developing new therapies for liver cancer. He is the author or co-author of more than 400 published manuscripts and abstracts, primarily on subjects dealing with liver cancer, and is also the recipient of numerous national and international awards and grants for his research in this field. As lead or co-investigator on more than 50 clinical trials, Dr. Geschwind’s research has been published in many top peer-reviewed journals, including the Journal of Clinical Oncology, Radiology, Hepatology, Clinical Cancer Research, Cancer Research and Annals of Surgery.
Dr. Geschwind serves on the editorial board of many journals and is a consultant to the Editor of Radiology as well as a reviewer for numerous radiology, hepatology and oncology journals. He is the current chairman of the World Conference on Interventional Oncology Board of Directors and is the chair of the Interventional Oncology Lecture Series for the RSNA. He is a Fellow of both the Society of Interventional Radiology (SIR) and the Cardiovascular and Interventional Radiology Society of Europe (CIRSE). He is a member of the Hepatobiliary Task Force of the National Cancer Institute and an active member of the American Association for Cancer Research, the American Society of Clinical Oncology, the International Liver Cancer Association, the Radiological Society of North America, the Society of Interventional Radiology and the Cardiovascular and Interventional Radiology Society of Europe. Dr. Geschwind is a Diplomate of the American Board of Radiology.